JSM 2012 Home

JSM 2012 Online Program

The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.

Online Program Home

Activity Details

530 Wed, 8/1/2012, 12:30 PM - 1:50 PM CC-Ballroom 20D
Biopharmaceutical Section P.M. Roundtable Discussion (fee event) — Roundtables PM Roundtable Discussion
Biopharmaceutical Section
Organizer(s): Estelle Russek-Cohen, FDA/CBER
WL11: Existing Practice and New Trends in Bioassay Lev Sirota, FDA
WL12: Postmarket Surveillance Issues Theodore Lystig, Medtronic
WL13: Evaluation of Sex Differences in Clinical Studies Chul Ahn, FDA/CDRH
WL14: Design a Clinical Trial: Sequential Design or Fixed Sample Size Design? Judy Li, FDA
WL15: Testing the Assumptions of Proportional Hazards
WL16: Guidelines on Handling Missing Data in Clinical Trials: Present and Future — Xin Zhao, Janssen Al ; Jianing Di, Janssen Alzheimer Immunotherapy R&D, LLC

2012 JSM Online Program Home

For information, contact jsm@amstat.org or phone (888) 231-3473.

If you have questions about the Continuing Education program, please contact the Education Department.